Skip to cookie consent Skip to main content

Adam Koppel, MD, PhD

Managing Director, Bain Capital Life Sciences Fund

Dr. Adam Koppel rejoined Bain Capital in 2016 as managing director of the Bain Capital Life Sciences Fund. He had initially joined Bain Capital Public Equity in 2003, where he was a leader within the health care sector until mid-2014. During mid-2014 to mid-2016, Dr. Koppel was at Biogen, where he served as executive vice president of corporate development and chief strategy officer. He sits on the board of directors of PTC Therapeutics (NASD: PTCT) and Trevena (NASD:TRVN). 


Prior to joining Bain Capital in 2003, Dr. Koppel was an associate principal at McKinsey & Co in New Jersey, where he served a variety of health care companies. Dr. Koppel received a medical degree and a PhD in neuroscience from the University of Pennsylvania School of Medicine. He also received a master of business administration from The Wharton School at the University of Pennsylvania, where he was a palmer scholar. He graduated magna cum laude from Harvard University with a bachelor of arts and master of arts in history and science.